Addressing patient to patient variability for autologous CAR T therapies.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of pharmaceutical sciences"
DOI: 10.1016/j.xphs.2020.12.015
Abstract: Chimeric Antigen Receptor (CAR) T cell therapy clinical trials have had unprecedented success in the endeavors to cure cancer patients, particularly those having hematological cancers. As researchers learn more about the ways to make CAR… read more here.
Keywords: addressing patient; patient variability; car cells; cancer patients ... See more keywords